Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases

被引:85
|
作者
Mariotto, Sara [1 ]
Gajofatto, Alberto [1 ]
Batzu, Lucia [2 ]
Delogu, Rachele [2 ]
Sechi, GianPietro [2 ]
Leoni, Stefania [2 ]
Pirastru, Maria Immacolata [2 ]
Bonetti, Bruno [3 ]
Zanoni, Mattia [1 ]
Alberti, Daniela [1 ]
Schanda, Kathrin [4 ]
Monaco, Salvatore [1 ]
Reindl, Markus [4 ]
Ferrari, Sergio [1 ]
机构
[1] Univ Verona, Dept Neurosci Biomed & Movement Sci, Sect Neurol, Verona, Italy
[2] Univ Sassari, Dept Med Surg & Expt Sci, Neurol Unit, Sassari, Italy
[3] AOUI Verona, Neurol Unit, Verona, Italy
[4] Med Univ Innsbruck, Clin Dept Neurol, Innsbruck, Austria
关键词
MOG-IGG; SPECTRUM;
D O I
10.1212/WNL.0000000000008479
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To determine the diagnostic relevance of myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) in CSF of seronegative cases by retrospectively analyzing consecutive time-matched CSF of 80 MOG-Ab-seronegative patients with demyelinating disease. Methods The cohort included 44 patients with NMOSD and related disorders and 36 patients with multiple sclerosis (MS). Two independent neurologists blinded to diagnosis analyzed MOG-Abs by live cell-based immunofluorescence assay with goat anti-human immunoglobulin (Ig) G (whole molecule) antibody. Sera were tested at dilutions of 1:20 and 1:40, and a cutoff of 1:160 was considered for serum positivity. CSF specimens were tested undiluted and at 1:2 dilution with further titrations in case of positivity. Anti-IgG-Fc and anti-IgM-mu secondary antibodies were used to confirm the exclusive presence of MOG-IgG in positive cases. CSF of 13 MOG-Abs seropositive cases and 36 patients with neurodegenerative conditions was analyzed as controls. Results Three seronegative cases had CSF MOG-Abs (4% of the whole cohort or 7% of cases excluding patients with MS, in which MOG-Abs seem to lack diagnostic relevance). In particular, 2 patients with neuromyelitis optica spectrum disorder (NMOSD) and 1 with acute disseminated encephalomyelitis had MOG-Abs in CSF. Analysis with anti-IgG-Fc and anti-IgM confirmed the exclusive presence of MOG-IgG in the CSF of these patients. Among the control group, MOG-Abs were detectable in the CSF of 8 of 13 MOG-Ab-seropositive cases and in none of the patients with neurodegenerative disorders. Conclusion Although serum is the optimal specimen for MOG-Ab testing, analyzing CSF could improve diagnostic sensitivity in seronegative patients. This observation has relevant diagnostic impact and might provide novel insight into the biological mechanisms of MOG-Ab synthesis.
引用
收藏
页码:E1867 / E1872
页数:6
相关论文
共 50 条
  • [21] Trends, Features, and Utility of Testing Myelin Oligodendrocyte Glycoprotein Autoantibodies in CSF
    Burton, Jodie
    Youn, Saerom
    Al-Ani, Abdullah
    Costello, Fiona
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 560 - 560
  • [22] Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis
    Reder, AT
    Oger, JJ
    NEUROLOGY, 2004, 62 (11) : 1922 - 1923
  • [24] The Potential Pathogenicity of Myelin Oligodendrocyte Glycoprotein Antibodies in the Optic Pathway
    Lerch, Magdalena
    Bauer, Angelika
    Reindl, Markus
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2023, 43 (01) : 5 - 16
  • [25] Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis
    Ramanathan, Sudarshini
    Reddel, Stephen W.
    Henderson, Andrew
    Parratt, John D. E.
    Barnett, Michael
    Gatt, Prudence N.
    Merheb, Vera
    Kumaran, Raani-Yogeeta Anusuiya
    Pathmanandavel, Karrnan
    Sinmaz, Nese
    Ghadiri, Mahtab
    Yiannikas, Con
    Vucic, Steve
    Stewart, Graeme
    Bleasel, Andrew F.
    Booth, David
    Fung, Victor S. C.
    Dale, Russell C.
    Brilot, Fabienne
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2014, 1 (04):
  • [26] Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis
    Ramanathan, Sudarshini
    Reddel, Stephen
    Henderson, Andrew
    Parratt, John
    Barnett, Michael
    Gatt, Prudence
    Merheb, Vera
    Kumaran, Raani-yogeeta
    Pathmanandavel, Karrnan
    Sinmaz, Nese
    Ghadiri, Mahtab
    Yiannikas, Con
    Vucic, Steve
    Stewaert, Graeme
    Bleasel, Andrew
    Booth, David
    Fung, Victor
    Dale, Russell
    Brilot, Fabienne
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 23 - 24
  • [27] Do Myelin Oligodendrocyte Glycoprotein Antibodies Represent a Distinct Syndrome?
    Chen, John J.
    Fraser, Clare L.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2019, 39 (03) : 416 - 423
  • [28] Elevated Intrathecal Myelin Oligodendrocyte Glycoprotein Antibodies in Multiple Sclerosis
    Klawiter, Eric C.
    Piccio, Laura
    Lyons, Jeri-Anne
    Mikesell, Robert
    O'Connor, Kevin C.
    Cross, Anne H.
    ARCHIVES OF NEUROLOGY, 2010, 67 (09) : 1102 - 1108
  • [29] Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder
    Ungureanu, A.
    de Seze, J.
    Ahle, G.
    Sellal, F.
    REVUE NEUROLOGIQUE, 2018, 174 (10) : 675 - 679
  • [30] Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology
    Marta, CB
    Oliver, AR
    Sweet, RA
    Pfeiffer, SE
    Ruddle, NH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (39) : 13992 - 13997